Shuttle Pharma's Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONE
Express News | Shuttle Pharmaceuticals Appoints Timothy J. Lorber As Chief Financial Officer; Part-Time Role Transitioning To Full-Time On September 10, 2024
Express News | Shuttle Pharmaceuticals: Michael Vander Hoek Will Be Transitioning Out of His Role as Chief Financial Officer
Express News | Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer
Press Release: Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer
12 Health Care Stocks Moving In Tuesday's After-Market Session
Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
Express News | Shuttle Pharmaceuticals Q1 EPS $(0.10) Down From $(0.07) YoY
Express News | Shuttle Pharmaceuticals Holdings Inc - We Expect to Have 'first Patient, First Dose' in Q2 of 2024
Express News | Shuttle Pharma Provides First Quarter 2024 Corporate Update
Shuttle Pharmaceuticals | 10-Q: Quarterly report
Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
Shuttle Pharmaceuticals Files to Sell Subscription Rights to Buy $4.5M in Units
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024
Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
12 Health Care Stocks Moving In Friday's After-Market Session
Express News | Shuttle Pharmaceuticals Q4 EPS $(0.11) Down From $(0.06) YoY
Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update
Express News | Shuttle Pharmaceuticals Has Been Granted European Patent Number EP3737376 Titled "Selective Histone Deacetylase Inhibitors For The Treatment Of Human Diseases (Including Cancers, Neurological Disorders, And Immunological Disorders)"
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024
No Data